ConductScience.org, home

Paper95208

Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells.

Williams BR and 4 others. Nature, 1979. Cited by 224 papers, by iCite.

Cite this record

ConductScience Library. Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells. Papers, record 95208. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/95208

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells.
PubMed
Journal
Nature
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
224
iCite
Relative citation ratio, by iCite
5.24
iCite
Revised in PubMed
2026-10-28
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Williams BRB R
2Golgher RRR R
3Brown RER E
4Gilbert CSC S
5Kerr IMI M

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenine NucleotidesMajor topic
InterferonsMajor topic
OligonucleotidesMajor topic
OligoribonucleotidesMajor topic
Virus ReplicationMajor topic
Animals
Cell-Free System
Encephalomyocarditis virus
L Cells
Mice
RNA, Double-Stranded
RNA, Messenger

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1114998Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/114998PubMed
2226408Activation of a nuclease by pppA2'p5'A2'p5'A in intact cells.FEBS Lett1979https://conductscience.org/library/papers/226408PubMed
34325000Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates.Proc Natl Acad Sci U S A1971https://conductscience.org/library/papers/4325000PubMed
4560630Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells.Nature1977https://conductscience.org/library/papers/560630PubMed
54345494Mechanism of interferon action: inhibition of viral messenger ribonucleic acid translation in L-cell extracts.J Virol1972https://conductscience.org/library/papers/4345494PubMed
6274708Oligonucleotide inhibitor of protein synthesis made in extracts of interferon-treated chick embryo cells: comparison with the mouse low molecular weight inhibitor.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/274708PubMed
71271520Translation of murine leukemia virus RNA in cell-free systems from animal cells.J Virol1976https://conductscience.org/library/papers/1271520PubMed
8823012An efficient mRNA-dependent translation system from reticulocyte lysates.Eur J Biochem1976https://conductscience.org/library/papers/823012PubMed
9283387Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/283387PubMed
104366491Increased sensitivity of cell-free protein synthesis to double-stranded RNA after interferon treatment.Nature1974https://conductscience.org/library/papers/4366491PubMed
11657268Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.Cell1978https://conductscience.org/library/papers/657268PubMed
12216547Synthesis and breakdown of pppA2'p5'A2'p5'A and transient inhibiton of protein synthesis in extracts from interferon-treated and control cells.Eur J Biochem1978https://conductscience.org/library/papers/216547PubMed
13424314Metabolic stability of 2' 5'oligo (A) and activity of 2' 5'oligo (A)-dependent endonuclease in extracts of interferon-treated and control HeLa cells.Nucleic Acids Res1979https://conductscience.org/library/papers/424314PubMed
14450698The respective roles of the protein kinase and pppA2' p5' A2' p5 A-activated endonuclease in the inhibition of protein synthesis by double stranded RNA in rabbit reticulocyte lysates.Nucleic Acids Res1979https://conductscience.org/library/papers/450698PubMed
15272640pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/272640PubMed
164500532-5A synthetase: assay, distribution and variation with growth or hormone status.Nature1979https://conductscience.org/library/papers/450053PubMed
174559581Interferon inhibits viral protein synthesis in L cells infected with vaccinia virus.Nature1972https://conductscience.org/library/papers/4559581PubMed
185263022On the biosynthesis and structure of double-stranded RNA in vaccinia virus-infected cells.Proc Natl Acad Sci U S A1969https://conductscience.org/library/papers/5263022PubMed
19740027Inhibition of protein synthesis by 2'-5' linked adenine oligonucleotides in intact cells.Nature1978https://conductscience.org/library/papers/740027PubMed
20208001Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A.Nature1978https://conductscience.org/library/papers/208001PubMed

See all 29 referencesDownload CSV of references

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 224 citations.

PMIDTitleJournalYearIn PapersSource
28418037Mitochondrial C11orf83 is a potent Antiviral Protein Independent of interferon production.Sci Rep2017https://conductscience.org/library/papers/28418037PubMed
26760998The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response.Int J Mol Sci2016https://conductscience.org/library/papers/26760998PubMed
25925578Structural and functional analysis reveals that human OASL binds dsRNA to enhance RIG-I signaling.Nucleic Acids Res2015https://conductscience.org/library/papers/25925578PubMed
25275129The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.J Virol2014https://conductscience.org/library/papers/25275129PubMed
23913960Role of ribonuclease L in viral pathogen-associated molecular pattern/influenza virus and cigarette smoke-induced inflammation and remodeling.J Immunol2013https://conductscience.org/library/papers/23913960PubMed
22202089Pathologic effects of RNase-L dysregulation in immunity and proliferative control.Front Biosci (Schol Ed)2012https://conductscience.org/library/papers/22202089PubMed
20844035Extracellular 2'-5' oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity.J Virol2010https://conductscience.org/library/papers/20844035PubMed
19411840Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence.RNA Biol2009https://conductscience.org/library/papers/19411840PubMed
17804500Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.J Virol2007https://conductscience.org/library/papers/17804500PubMed
17681844A scientific journey through the 2-5A/RNase L system.Cytokine Growth Factor Rev2007https://conductscience.org/library/papers/17681844PubMed
17400356Diverse functions of RNase L and implications in pathology.Biochimie2007https://conductscience.org/library/papers/17400356PubMed
16501108RNase L plays a role in the antiviral response to West Nile virus.J Virol2006https://conductscience.org/library/papers/16501108PubMed
11967338Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.J Virol2002https://conductscience.org/library/papers/11967338PubMed
9847332RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells.J Virol1999https://conductscience.org/library/papers/9847332PubMed
9623881The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.Pharmacol Ther1998https://conductscience.org/library/papers/9623881PubMed
9525594RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection.J Virol1998https://conductscience.org/library/papers/9525594PubMed
9351818Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L.EMBO J1997https://conductscience.org/library/papers/9351818PubMed
9050883Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9050883PubMed
8725108Brefeldin A inhibits the antiviral action of interferon against encephalomyocarditis virus.Virus Res1996https://conductscience.org/library/papers/8725108PubMed
7688298A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon.EMBO J1993https://conductscience.org/library/papers/7688298PubMed

See all 49 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/95208

GET https://conductscience.org/api/papers/v1/95208/references?page=2